Siemens Healthcare has announced that the U.S. Food and Drug Administration (FDA) recently cleared the company’s CAIPIRINHA (Controlled Aliasing in Volumetric Parallel Imaging Results IN Higher Acceleration) software as part of Siemens’ syngo MR D13A software package for parallel magnetic resonance (MR) imaging. The software helps enable patients with breath-holding difficulties to reduce the amount of time they hold their breath by up to 50 percent without sacrificing imaging resolution or contrast.
Â
